Kia ora Mr. Richards,

 

Thank you for your request under the Official Information Act 1982 (the
Act), received by the Ministry of Health - Manatû Hauora on 7 April 2026.
You requested:

 

"1- All documents, briefings, minutes, emails, risk assessments,
modelling, or internal advice prepared or considered by the Ministry of
Health, Te Whatu Ora, or the Immunisation Advisory Centre (IMAC) when
deciding — in the 27 March 2026 amendments to Chapter 5 of the
Immunisation Handbook — to retain a routine recommendation for a primary
COVID-19 vaccine course (one dose for healthy previously unvaccinated
individuals aged 5 years and over; two doses for severely
immunocompromised individuals aged 5 years and over), while simultaneously
advising that additional doses are “not routinely recommended” for healthy
adults aged 30–64 years due to lower clinical risk of severe infection and
high population hybrid immunity.

2- Any epidemiological modelling, cohort studies, or risk-benefit analyses
(using 2025–2026 data) assessing the incremental benefit of a primary dose
(or two-dose primary course) in previously unvaccinated healthy or
immunocompromised individuals against severe COVID-19 outcomes,
hospitalisation, or death under current endemic conditions with
LP.8.1-lineage strains and widespread hybrid immunity.

3- The most recent surveillance data (2025–2026) on severe COVID-19
outcomes in the remaining unvaccinated population (including those
eligible for a primary course) compared with those possessing hybrid
immunity, stratified by age group, comorbidity status, and ethnicity.

4- Updated analyses of adverse event rates (particularly
myocarditis/pericarditis and any other serious events) following a primary
COVID-19 vaccine dose (or two-dose course) in previously unvaccinated
healthy or immunocompromised individuals aged 5–64 years, including
comparison to infection-related risks in 2026.

5- Any cost-effectiveness, health-economic, or resource-allocation
assessments for continuing to recommend and publicly fund primary COVID-19
vaccination (one- or two-dose courses) for previously unvaccinated
individuals when routine additional-dose recommendations have been
narrowed for the same low-risk groups.

6- Any internal advice or modelling addressing (a) equity impacts
(including for Mâori and Pacific populations) of retaining the current
primary-course recommendation versus (b) moving the primary course to a
shared clinical decision-making / optional model only, consistent with the
approach taken for additional doses in healthy 30–64 year-olds.

7- All correspondence, briefings, advice, or assessments exchanged between
the Ministry of Health / Te Whatu Ora and the New Zealand Defence Force
(NZDF) concerning NZDF’s “further review” of its baseline vaccination
schedule triggered by the 27 March 2026 Immunisation Handbook changes.
This includes any evaluation of how the risk-stratified approach and
reduced routine recommendations for healthy adults apply to NZDF serving
members and recruits, with specific reference to NZDF OIA-2026-5687 and
follow-up request 34315 (including impacts on recruitment, retention, the
~164 previously discharged personnel, and NZDF’s status as the only
remaining Five Eyes nation with a COVID-19 baseline requirement)."
 

The reference number for your request is H2026081071. We will endeavour to
respond to your request as soon as possible and in any event no later than
6 May 2026 being 20 working days after the day your request was received.
If we are unable to respond to your request by then, we will notify you of
an extension of that timeframe.

 

If you have any queries regarding your request, please feel free to
contact the OIA Services Team on [1][email address]. If any
additional factors come to light which are relevant to your request,
please do not hesitate to contact us so that these can be taken into
account. 

 

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.

 

 

Ngâ mihi, 
 
OIA Services Team

Ministry of Health | Manatû Hauora

 

M[3]inistry of Health information releases

 

show quoted sections

References

Visible links
1. mailto:[email address]
mailto:[email address]
2. mailto:[email address]
mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
https://www.health.govt.nz/about-ministr...

Tēnā koe Mr. Richards,

 

Please find attached a letter notifying you of partial transfer of your
request (ref: H2026081071) under section 14(b)(ii) of the Act. 

 

If you have any concerns or queries, please do not hesitate to get in
touch with the OIA team at: [1][email address].

 

Ngā mihi,

 
 

OIA Services Team

Ministry of Health | Manatū Hauora

 

show quoted sections

References

Visible links
1. mailto:[email address]

Dear Mr. Richards, 

 

Thank you for your Official Information Act 1982 (the Act) request,
received on 17^th April 2026, in which you requested the following
information: 

 

 5- Any cost-effectiveness, health-economic, or resource-allocation
assessments for continuing to recommend and publicly fund primary COVID-19
vaccination (one- or two-dose courses) for previously unvaccinated
individuals when routine additional-dose recommendations have been
narrowed for the same low-risk groups.

 

Your request will be answered within the provisions of the Official
Information Act. 

 

Kind regards, 

 

[1]Image Office of Hon Simeon Brown

Minister of Health, Minister for State Owned Enterprises,
Minister for Energy
Email: [2][email address]

Private Bag 18041, Parliament Buildings, Wellington 6160, New
Zealand

 

show quoted sections

Tçnâ koe Mr Richards,
 
Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health – Manatû Hauora on 7 April 2026. You
requested:
"1- All documents, briefings, minutes, emails, risk assessments,
modelling, or internal advice prepared or considered by the Ministry of
Health, Te Whatu Ora, or the Immunisation Advisory Centre (IMAC) when
deciding — in the 27 March 2026 amendments to Chapter 5 of the
Immunisation Handbook — to retain a routine recommendation for a primary
COVID-19 vaccine course (one dose for healthy previously unvaccinated
individuals aged 5 years and over; two doses for severely
immunocompromised individuals aged 5 years and over), while simultaneously
advising that additional doses are “not routinely recommended” for healthy
adults aged 30–64 years due to lower clinical risk of severe infection and
high population hybrid immunity.
2- Any epidemiological modelling, cohort studies, or risk-benefit analyses
(using 2025–2026 data) assessing the incremental benefit of a primary dose
(or two-dose primary course) in previously unvaccinated healthy or
immunocompromised individuals against severe COVID-19 outcomes,
hospitalisation, or death under current endemic conditions with
LP.8.1-lineage strains and widespread hybrid immunity.
3- The most recent surveillance data (2025–2026) on severe COVID-19
outcomes in the remaining unvaccinated population (including those
eligible for a primary course) compared with those possessing hybrid
immunity, stratified by age group, comorbidity status, and ethnicity.
4- Updated analyses of adverse event rates (particularly
myocarditis/pericarditis and any other serious events) following a primary
COVID-19 vaccine dose (or two-dose course) in previously unvaccinated
healthy or immunocompromised individuals aged 5–64 years, including
comparison to infection-related risks in 2026.
6- Any internal advice or modelling addressing (a) equity impacts
(including for Mâori and Pacific populations) of retaining the current
primary-course recommendation versus (b) moving the primary course to a
shared clinical decision-making / optional model only, consistent with the
approach taken for additional doses in healthy 30–64 year-olds.
7- All correspondence, briefings, advice, or assessments exchanged between
the Ministry of Health / Te Whatu Ora and the New Zealand Defence Force
(NZDF) concerning NZDF’s “further review” of its baseline vaccination
schedule triggered by the 27 March 2026 Immunisation Handbook changes.
This includes any evaluation of how the risk-stratified approach and
reduced routine recommendations for healthy adults apply to NZDF serving
members and recruits, with specific reference to NZDF OIA-2026-5687 and
follow-up request 34315 (including impacts on recruitment, retention, the
~164 previously discharged personnel, and NZDF’s status as the only
remaining Five Eyes nation with a COVID-19 baseline requirement)."
Part of your request asks for information which is held by Health New
Zealand – Te Whatu Ora. For this reason, part 1 of your request is being
transferred to their agency under section 14(b)(i) of the Act. You can
expect a response from Te Whatu Ora in due course
([1][email address]). The Ministry will endeavour to respond to
the remaining parts of your request by 6 May 2026 being 20 working days
after your request was received.  
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review the Ministry’s decision to transfer your request. The Ombudsman may
be contacted by email at: [2][email address] or by calling
0800 802 602.
  
Ngâ mihi,

OIA Services Team

Ministry of Health | Manatû Hauora

show quoted sections

References

Visible links
1. mailto:[email address]
2. mailto:[email address]

Tçnâ koe Mr Richards,
 
Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health – Manatû Hauora on 7 April 2026. You
requested:
"1- All documents, briefings, minutes, emails, risk assessments,
modelling, or internal advice prepared or considered by the Ministry of
Health, Te Whatu Ora, or the Immunisation Advisory Centre (IMAC) when
deciding — in the 27 March 2026 amendments to Chapter 5 of the
Immunisation Handbook — to retain a routine recommendation for a primary
COVID-19 vaccine course (one dose for healthy previously unvaccinated
individuals aged 5 years and over; two doses for severely
immunocompromised individuals aged 5 years and over), while simultaneously
advising that additional doses are “not routinely recommended” for healthy
adults aged 30–64 years due to lower clinical risk of severe infection and
high population hybrid immunity.
2- Any epidemiological modelling, cohort studies, or risk-benefit analyses
(using 2025–2026 data) assessing the incremental benefit of a primary dose
(or two-dose primary course) in previously unvaccinated healthy or
immunocompromised individuals against severe COVID-19 outcomes,
hospitalisation, or death under current endemic conditions with
LP.8.1-lineage strains and widespread hybrid immunity.
3- The most recent surveillance data (2025–2026) on severe COVID-19
outcomes in the remaining unvaccinated population (including those
eligible for a primary course) compared with those possessing hybrid
immunity, stratified by age group, comorbidity status, and ethnicity.
4- Updated analyses of adverse event rates (particularly
myocarditis/pericarditis and any other serious events) following a primary
COVID-19 vaccine dose (or two-dose course) in previously unvaccinated
healthy or immunocompromised individuals aged 5–64 years, including
comparison to infection-related risks in 2026.
6- Any internal advice or modelling addressing (a) equity impacts
(including for Mâori and Pacific populations) of retaining the current
primary-course recommendation versus (b) moving the primary course to a
shared clinical decision-making / optional model only, consistent with the
approach taken for additional doses in healthy 30–64 year-olds.
7- All correspondence, briefings, advice, or assessments exchanged between
the Ministry of Health / Te Whatu Ora and the New Zealand Defence Force
(NZDF) concerning NZDF’s “further review” of its baseline vaccination
schedule triggered by the 27 March 2026 Immunisation Handbook changes.
This includes any evaluation of how the risk-stratified approach and
reduced routine recommendations for healthy adults apply to NZDF serving
members and recruits, with specific reference to NZDF OIA-2026-5687 and
follow-up request 34315 (including impacts on recruitment, retention, the
~164 previously discharged personnel, and NZDF’s status as the only
remaining Five Eyes nation with a COVID-19 baseline requirement)."
After consulting further with Health New Zealand - Te Whatu Ora, the
Ministry has determined that additional parts of your request ask for
information which is more closely aligned with the functions of their
agency. For this reason, in addition to part 1 which was transferred on 21
April, parts 2, 3, 6 and 7 of your request are being transferred to Health
New Zealand under section 14(b)(ii) of the Act. You can expect a response
from Te Whatu Ora in due course ([1][email address]). 
The Ministry would like to apologise for the delay in transferring your
request and for any inconvenience this may have caused. We will endeavour
to respond to part 4 of your request by 6 May 2026 being 20 working days
after your request was received.  
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review the Ministry’s decision to transfer your request. The Ombudsman may
be contacted by email at: [2][email address] or by calling
0800 802 602.
  
Ngâ mihi,

OIA Services Team

Ministry of Health | Manatû Hauora

show quoted sections

References

Visible links
1. mailto:[email address]
mailto:[email address]
2. mailto:[email address]
mailto:[email address]

Tçnâ koe,

 

Thank you for your email. 

 

Under the Official Information Act (OIA), agencies are required to respond
to requests for official information as soon as reasonably practicable and
no later than 20 working days after receiving them.

If your request is for data that Health NZ holds, have you checked
[1]Lighthouse first to see if the data you are seeking is already
published?

 

Lighthouse is a searchable catalogue that makes a range of data and
analytics products available to New Zealanders to enable easier, faster
access to insights about health services.

 

You can find further information about how OIA timeframes are calculated,
including the Ombudsman’s OIA calculator, at the link below:
[2]Official information calculators | Ombudsman New Zealand

 

We will provide a response to your request in line with the statutory
timeframes set out in the OIA.

We appreciate your understanding and patience during this time.

 

Ngâ mihi,
Health NZ | Te Whatu Ora

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

References

Visible links
1. https://www.tewhatuora.govt.nz/for-healt...
https://www.tewhatuora.govt.nz/for-healt...
2. https://aus01.safelinks.protection.outlo...
https://www.ombudsman.parliament.nz/agen...

Kia ora Mr Richards,
 
Thank you for your request, transferred from the Ministry of Health on 22
April 2026, for the following information:
 

"1- All documents, briefings, minutes, emails, risk assessments,
modelling, or internal advice prepared or considered by the Ministry of
Health, Te Whatu Ora, or the Immunisation Advisory Centre (IMAC) when
deciding — in the 27 March 2026 amendments to Chapter 5 of the
Immunisation Handbook — to retain a routine recommendation for a primary
COVID-19 vaccine course (one dose for healthy previously unvaccinated
individuals aged 5 years and over; two doses for severely
immunocompromised individuals aged 5 years and over), while simultaneously
advising that additional doses are “not routinely recommended” for healthy
adults aged 30–64 years due to lower clinical risk of severe infection and
high population hybrid immunity.
2- Any epidemiological modelling, cohort studies, or risk-benefit analyses
(using 2025–2026 data) assessing the incremental benefit of a primary dose
(or two-dose primary course) in previously unvaccinated healthy or
immunocompromised individuals against severe COVID-19 outcomes,
hospitalisation, or death under current endemic conditions with
LP.8.1-lineage strains and widespread hybrid immunity.
3- The most recent surveillance data (2025–2026) on severe COVID-19
outcomes in the remaining unvaccinated population (including those
eligible for a primary course) compared with those possessing hybrid
immunity, stratified by age group, comorbidity status, and ethnicity.
6- Any internal advice or modelling addressing (a) equity impacts
(including for Māori and Pacific populations) of retaining the current
primary-course recommendation versus (b) moving the primary course to a
shared clinical decision-making / optional model only, consistent with the
approach taken for additional doses in healthy 30–64 year-olds.
7- All correspondence, briefings, advice, or assessments exchanged between
the Ministry of Health / Te Whatu Ora and the New Zealand Defence Force
(NZDF) concerning NZDF’s “further review” of its baseline vaccination
schedule triggered by the 27 March 2026 Immunisation Handbook changes.
This includes any evaluation of how the risk-stratified approach and
reduced routine recommendations for healthy adults apply to NZDF serving
members and recruits, with specific reference to NZDF OIA-2026-5687 and
follow-up request 34315 (including impacts on recruitment, retention, the
~164 previously discharged personnel, and NZDF’s status as the only
remaining Five Eyes nation with a COVID-19 baseline requirement)."

 
Part 7 of your request asks for information which is more closely aligned
with the functions of New Zealand Defence Force (NZDF).  
For this reason, Health New Zealand has decided to transfer part 7 of your
request to NZDF under section 14(b)(ii) of the Official Information Act
(OIA).
You can expect a response from them in due course.
 
Under section 28(3) of the OIA you have the right to ask the Ombudsman
to review any decisions made under this request. 
The Ombudsman may be contacted
by email at: [1][email address] or by calling 0800 802 602. 
If you have any queries related to this request, please do not hesitate to
get in touch.  
 
Ngā mihi  

 

Pamela

Government Services (OIA)

[2][email address]

Health New Zealand | Te Whatu Ora

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

References

Visible links
1. mailto:[email address]
2. mailto:[email address]

 

Good morning Mr Richards

 

Part 7 of your request below has been received by the New Zealand Defence
Force and a decision on your request will be provided as soon as possible
and no later than 28 May 2026. Responses to requests for information that
are considered to be in the wider public interest will be published on the
New Zealand Defence Force website ([1]www.nzdf.mil.nz).

 

Regards

 

Corporate and Ministerial Services
Office of the Chief of Defence Force
New Zealand Defence Force | Te Ope Kātua o Aotearoa

[2]www.nzdf.mil.nz

 

 

From: hnzOIA [[3]mailto:[email address]]
Sent: Thursday, 30 April 2026 8:47 a.m.
To: Mr Richards <[4][FOI #34407 email]>
Subject: Partial transfer of your request for official information
(HNZ00202714) CRM:0275065

 

Kia ora Mr Richards,

 

Thank you for your request, transferred from the Ministry of Health on 22
April 2026, for the following information:

 

"1- All documents, briefings, minutes, emails, risk assessments,
modelling, or internal advice prepared or considered by the Ministry of
Health, Te Whatu Ora, or the Immunisation Advisory Centre (IMAC) when
deciding — in the 27 March 2026 amendments to Chapter 5 of the
Immunisation Handbook — to retain a routine recommendation for a primary
COVID-19 vaccine course (one dose for healthy previously unvaccinated
individuals aged 5 years and over; two doses for severely
immunocompromised individuals aged 5 years and over), while simultaneously
advising that additional doses are “not routinely recommended” for healthy
adults aged 30–64 years due to lower clinical risk of severe infection and
high population hybrid immunity.
2- Any epidemiological modelling, cohort studies, or risk-benefit analyses
(using 2025–2026 data) assessing the incremental benefit of a primary dose
(or two-dose primary course) in previously unvaccinated healthy or
immunocompromised individuals against severe COVID-19 outcomes,
hospitalisation, or death under current endemic conditions with
LP.8.1-lineage strains and widespread hybrid immunity.
3- The most recent surveillance data (2025–2026) on severe COVID-19
outcomes in the remaining unvaccinated population (including those
eligible for a primary course) compared with those possessing hybrid
immunity, stratified by age group, comorbidity status, and ethnicity.
6- Any internal advice or modelling addressing (a) equity impacts
(including for Māori and Pacific populations) of retaining the current
primary-course recommendation versus (b) moving the primary course to a
shared clinical decision-making / optional model only, consistent with the
approach taken for additional doses in healthy 30–64 year-olds.
7- All correspondence, briefings, advice, or assessments exchanged between
the Ministry of Health / Te Whatu Ora and the New Zealand Defence Force
(NZDF) concerning NZDF’s “further review” of its baseline vaccination
schedule triggered by the 27 March 2026 Immunisation Handbook changes.
This includes any evaluation of how the risk-stratified approach and
reduced routine recommendations for healthy adults apply to NZDF serving
members and recruits, with specific reference to NZDF OIA-2026-5687 and
follow-up request 34315 (including impacts on recruitment, retention, the
~164 previously discharged personnel, and NZDF’s status as the only
remaining Five Eyes nation with a COVID-19 baseline requirement)."

 

Part 7 of your request asks for information which is more closely aligned
with the functions of New Zealand Defence Force (NZDF).  

For this reason, Health New Zealand has decided to transfer part 7 of your
request to NZDF under section 14(b)(ii) of the Official Information Act
(OIA).

You can expect a response from them in due course.

 

Under section 28(3) of the OIA you have the right to ask the Ombudsman
to review any decisions made under this request. 

The Ombudsman may be contacted
by email at: [5][email address] or by calling 0800 802 602. 

If you have any queries related to this request, please do not hesitate to
get in touch.  
 

Ngā mihi  

 

Pamela

Government Services (OIA)

[6][email address]

Health New Zealand | Te Whatu Ora

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

The information contained in this Internet Email message is intended for
the addressee only and may contain privileged information, but not
necessarily the official views or opinions of the New Zealand Defence
Force.  If you are not the intended recipient you must not use, disclose,
copy or
distribute this message or the information in it.  If you have received
this message in error, please Email or telephone the sender immediately.

References

Visible links
1. http://www.nzdf.mil.nz/
2. http://www.nzdf.mil.nz
http://www.nzdf.mil.nz/
3. mailto:[email address]
4. mailto:[FOI #34407 email]
5. mailto:[email address]
6. mailto:[email address]

Kia ora,  
 
Please find attached the response for your request for official
information. 
Ngā mihi,

OIA Services Team

Ministry of Health | Manatū Hauora

show quoted sections

Kia ora Mr Richards,
 
Thank you for your request of 22/04/2026 for the following information:
 

1- All documents, briefings, minutes, emails, risk assessments, modelling,
or internal advice prepared or considered by the Ministry of Health, Te
Whatu Ora, or the Immunisation Advisory Centre (IMAC) when deciding — in
the 27 March 2026 amendments to Chapter 5 of the Immunisation Handbook —
to retain a routine recommendation for a primary COVID-19 vaccine course
(one dose for healthy previously unvaccinated individuals aged 5 years and
over; two doses for severely immunocompromised individuals aged 5 years
and over), while simultaneously advising that additional doses are “not
routinely recommended” for healthy adults aged 30–64 years due to lower
clinical risk of severe infection and high population hybrid immunity.
 

This part of your request asks for information which is more closely
aligned with the functions of the Immunisation Advisory Centre (IMAC). 
For this reason, Health New Zealand has decided to transfer part 1 of your
request to IMAC under section 14(b)(ii) of the Official Information Act
(OIA).
You can expect a response from them in due course. They can be contacted
at [1][email address]
 
Health NZ will continue to respond to the remainder of your request: parts
2, 3 and 6. 
 
Under section 28(3) of the OIA you have the right to ask the Ombudsman
to review any decisions made under this request. 
The Ombudsman may be contacted
by email at: [2][email address] or by calling 0800 802 602. 
If you have any queries related to this request, please do not hesitate to
get in touch.  
 
Ngā mihi  

 

Pamela

Government Services (OIA)

[3][email address]

Health New Zealand | Te Whatu Ora

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

References

Visible links
1. mailto:[email address]
2. mailto:[email address]
3. mailto:[email address]

Dear Mr Richards,
I refer to your request of 6 May 2026 for official information under the
Official Information Act 1982.
The University will respond to your request as soon as reasonably
practicable, and within the Official Information Act’s maximum time limit
of 20 working days from the date of your request
(6 June 2026) unless that time limit is extended under the Act.
Yours sincerely,
Kamy Govender

show quoted sections

 

Good afternoon Mr Richards

 

Please find attached the response to your request for information.

 

Regards

 

Corporate and Ministerial Services

Office of the Chief of Defence Force

New Zealand Defence Force

[1]www.nzdf.mil.nz

 

 

The information contained in this Internet Email message is intended for
the addressee only and may contain privileged information, but not
necessarily the official views or opinions of the New Zealand Defence
Force.  If you are not the intended recipient you must not use, disclose,
copy or
distribute this message or the information in it.  If you have received
this message in error, please Email or telephone the sender immediately.

References

Visible links
1. http://www.nzdf.mil.nz/

Kia ora Mr Richards,
 
Thank you for your request of 22 April 2026 for the following information:
 

2- Any epidemiological modelling, cohort studies, or risk-benefit analyses
(using 2025–2026 data) assessing the incremental benefit of a primary dose
(or two-dose primary course) in previously unvaccinated healthy or
immunocompromised individuals against severe COVID-19 outcomes,
hospitalisation, or death under current endemic conditions with
LP.8.1-lineage strains and widespread hybrid immunity.

3- The most recent surveillance data (2025–2026) on severe COVID-19
outcomes in the remaining unvaccinated population (including those
eligible for a primary course) compared with those possessing hybrid
immunity, stratified by age group, comorbidity status, and ethnicity.

6- Any internal advice or modelling addressing (a) equity impacts
(including for Māori and Pacific populations) of retaining the current
primary-course recommendation versus (b) moving the primary course to a
shared clinical decision-making / optional model only, consistent with the
approach taken for additional doses in healthy 30–64 year-olds.

 
We are writing to inform you that parts 2 and 6 of your request asks for
information which is more closely aligned with the functions of the
Immunisation Advisory Centre (IMAC).
For this reason, Health New Zealand has decided to partially transfer your
request under section 14(b)(ii) of the Official Information Act (OIA). We
apologise for not transferring these parts of your request sooner, when we
transferred part 1 to IMAC.
You can expect a response from IMAC in due course. They can be contacted
at [1][email address]
 
Under section 28(3) of the OIA you have the right to ask the Ombudsman
to review any decisions made under this request. 
The Ombudsman may be contacted
by email at: [2][email address] or by calling 0800 802 602. 
If you have any queries related to this request, please do not hesitate to
get in touch.  
 
Ngā mihi  

 

Pamela

Government Services (OIA)

[3][email address]

Health New Zealand | Te Whatu Ora

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

References

Visible links
1. mailto:[email address]
2. mailto:[email address]
3. mailto:[email address]

Kia ora Mr Richards, 
 
Thank you for your request for information regarding COVID-19 vaccine
course recommendations on 22 April 2026. Please find attached our response
to your request.
 
If you have any questions, please get in touch at
[1][email address]
 
If you are not happy with this response, you have the right to make a
complaint to the Ombudsman. Information about how to do this is available
at [2]www.ombudsman.parliament.nz or by phoning 0800 802 602.
 
Ngā mihi, 
 

Pamela

Government Services (OIA)

[3][email address]

Health New Zealand | Te Whatu Ora

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

References

Visible links
1. mailto:[email address]
2. file:///tmp/
3. mailto:[email address]

Dear Mr Richards,
 
I refer to your request of 13 May 2026, for official information under the
Official Information Act 1982.
The University will respond to your request as soon as reasonably
practicable, and within the Official Information Act’s maximum time limit
of 20 working days from the date of your request (11 June 2026) unless
that time limit is extended under the Act.
 
 
Yours sincerely,
Kamy Govender

show quoted sections

Dear Mr Richards

 

Please find attached the response to your Official Information Act
request, with reference SBOIA26-1088.

 

Kind regards,

 

[1]Image Office of Hon Simeon Brown

Minister of Health, Minister for Energy, Minister for State Owned
Enterprises
Email: [2][email address]

Private Bag 18041, Parliament Buildings, Wellington 6160, New
Zealand

From: Simeon Brown (MIN) <[email address]>
Sent: Tuesday, 21 April 2026 4:25 PM
To: [FOI #34407 email]
Subject: SBOIA26-1088 FW: Querying partial transfer - COVID-19 vaccine
course recommendations - H2026081071 CRM:0489277

 

Dear Mr. Richards, 

 

Thank you for your Official Information Act 1982 (the Act) request,
received on 17^th April 2026, in which you requested the following
information: 

 

 5- Any cost-effectiveness, health-economic, or resource-allocation
assessments for continuing to recommend and publicly fund primary COVID-19
vaccination (one- or two-dose courses) for previously unvaccinated
individuals when routine additional-dose recommendations have been
narrowed for the same low-risk groups.

 

Your request will be answered within the provisions of the Official
Information Act. 

 

Kind regards, 

 

[3]Image Office of Hon Simeon Brown

Minister of Health, Minister for State Owned Enterprises,
Minister for Energy
Email: [4][email address]

Private Bag 18041, Parliament Buildings, Wellington 6160, New
Zealand

 

show quoted sections